Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-24-023316
Filing Date
2024-06-10
Accepted
2024-06-10 14:00:56
Documents
1
Period of Report
2024-06-01

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2141
  Complete submission text file 0001493152-24-023316.txt   3860
Mailing Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648
Business Address 997 LENOX DRIVE SUITE 100 LAWRENCEVILLE NJ 08648 (609) 896-9100
Imunon, Inc. (Issuer) CIK: 0000749647 (see all company filings)

EIN.: 521256615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 733 CONCORD AVENUE C/O WAVE LIFE SCIENCES USA, INC. CAMBRIDGE MA 02138
Business Address
Gaiero David G (Reporting) CIK: 0001799784 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15911 | Film No.: 241032264